Combination treatment improves survival in cisplatin-eligible MIBC
Pembrolizumab and enfortumab vedotin reduce the risk of death, progression or recurrence in muscle invasive bladder cancer, Pfizer shared.
News
-
-
Experts create new recommendations for muscle-invasive bladder cancer
Combining surgery or radiation with new treatments can improve outcomes, concluded the International Bladder Cancer Group.
-
Researchers examine influence of carcinogens in bladder cancer
Scientists are developing new ways to stop carcinogens from causing bladder cancer.
-
Study shows tumor DNA guides safer bladder-sparing treatment
Nearly seven in 10 patients with bladder cancer with a complete response were alive with their bladder intact at three years.
-
Living in a disadvantaged area raises bladder cancer death risk
Where a patient lives and the resources in that neighborhood can influence the risk of dying from bladder cancer over time.
-
Researchers recommend making mental health care a priority in bladder cancer
Mental health care should be a bigger part of treatment for people with bladder cancer, according to a recent review.
-
Inactivated E. coli may offer a new treatment option for bladder cancer
Inactivated UPEC is a promising new way to prevent and treat bladder cancer.
-
Gene analysis highlights need for sex-specific bladder cancer treatment
A study found that hundreds of genes in early-stage bladder cancer tumors behave differently depending on a patient’s sex.
-
Microbiome in bladder cancer tissue differs from microbiome in urine
Urinary microbiomes do not reflect the microbiomes present in bladder cancer tissue.
-
Precision nutrition could open new frontiers in bladder cancer care, researchers say
A new research review suggests dietary strategies tailored to a person’s genes, metabolism and microbiome may help with bladder cancer care.